Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2429-2024Class II

Abbott Infinity 5, Implantable Pulse Generator, REF: 6660, SterileEO, Rx Only

Abbott Medical / initiated 2024-05-22 / Open, Classified / root cause: labeling and UDI

Abbott Medical began a recall of Abbott Infinity 5, Implantable Pulse Generator, REF: 6660, SterileEO, Rx Only on . FDA classified it as Class II and gives the reason as "Their is a potential that the implantable pulse generator replacement indicator and end of service date may be shorter than indicated in the product labeling potentially resulting in loss of therapy". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2429-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Abbott Medical
Product
Abbott Infinity 5, Implantable Pulse Generator, REF: 6660, SterileEO, Rx Only
Product code
MHY Stimulator, Electrical, Implanted, For Parkinsonian Tremor
Reason for recall
Their is a potential that the implantable pulse generator replacement indicator and end of service date may be shorter than indicated in the product labeling potentially resulting in loss of therapy.
Root cause tag
labeling and UDI
FDA root cause
Error in labeling
Action
On June 6, 2024, Abbott, issued a "Urgent Medical Device Correction" notification to affected consignees via mail. Abbott asked consignees to take the following actions: 1. This issue will continue to affect your patients for the foreseeable future. Abbott is working on an update to align the product labeling with actual device performance. 2. For information on when an ERI notification appears and how to make a determination with your patients on timing of IPG replacement, see the customer communication. 3. For recommended strategies for preventing lapse in therapy, see the customer communication. 4. Please inform your patients about this medical device correction letter. 5. Please return a completed Acknowledgement Form and maintain a record of this notice along with a copy of the completed Acknowledgement Form. 6. For questions about this issue or reported complaints, please contact your Abbott representative, or Abbott Technical Support at 1-800-727-7846. 7. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Quantity in commerce
5,900 units
Distribution
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, DC, FL, GA, IL, IN, KY, LA, MA, MD, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, PR, SC, TX, UT, VA, WA, WI, WY and the countries of Algeria, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Cyprus, Czech Republic, Ecuador, Estonia, Finland, France, Germany, Greece, Hungary, India, Ireland, Israel, Italy, Japan, Jordan, Korea, Lithuania, Mexico, Netherlands, Norway, Pakistan, Poland, Portugal, Russian Federation, Saudi Arabia, South Africa, Spain, Sweden, Taiwan, Turkey, United Arab Emirates, United Kingdom.
Product codes and lots
All Serial numbers/UDI:05415067030016/05415067020246

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2429-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2429-2024Class IIOngoingVoluntary: Firm initiated
Z-2430-2024Class IIOngoingVoluntary: Firm initiated
Z-2431-2024Class IIOngoingVoluntary: Firm initiated
Z-2432-2024Class IIOngoingVoluntary: Firm initiated